Indication
Primary Mitochondrial Myopathy
3 clinical trials
4 products
Product
REN001Clinical trial
An Open-label, Multi-centre Study to Evaluate the Long-term Safety and Tolerability of REN001 in Subjects With Primary Mitochondrial Myopathy (PMM)Status: Terminated, Estimated PCD: 2023-12-14
Product
MavodelparClinical trial
A Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of 24 Weeks Treatment With REN001 in Patients With Primary Mitochondrial MyopathyStatus: Completed, Estimated PCD: 2023-09-12
Product
PlaceboClinical trial
A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Assess the Efficacy, Safety and Tolerability of ASP0367 in Participants With Primary Mitochondrial MyopathyStatus: Terminated, Estimated PCD: 2024-04-09
Product
Bocidelpar